To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorViral N. Shah
About this trial
The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.
Eligibility criteria
Qualifiers
Age ≥18 years
Diagnosis of T1D for at least 12 months with stable insulin regimen for at least 2 months
HbA1c ≥8.0%
Diagnosis of gastroparesis per National Institute of Health (NIH) definition
Disqualifiers
Age <18 years
Current use of inhaled insulin (Afrezza)
Patients with T1D using any glucose lowering medications other than insulin at the time of screening
Pregnancy, breast feeding, or wanting to become pregnant
Trial design
Treatments tested in this trial
- Medtronic 780G AID
Treatment groups
34 Participants
are divided into 2 treatment groupsLocations
1Indiana University Health, Univeristy hospital46202, IndianapolisIndiana, United States
Sponsors and collaborators
Viral N. Shah
Lead sponsor
Indiana University
Sponsor institution
Medtronic
Collaborator
Source ClinicalTrials.gov